NIH decision to cap indirect costs sparks concern in scientific community

On February 7, 2025, the U.S. National Institutes of Health announced a decision to cap indirect cost reimbursement-which supports the critical infrastructure and staff that make biomedical research possible-at 15%. In a commentary published February 28 in the Cell Press journal Cell, molecular biologist Tom Maniatis of the New York Genome Center (NYGC) and Columbia… Continue reading NIH decision to cap indirect costs sparks concern in scientific community

Published
Categorized as Immunology

New target identified for preventing cold sores and genital herpes

Scientists have a new target to prevent cold sores after University of Virginia School of Medicine researchers discovered an unexpected way the herpes virus re-activates in the body. The finding could also have important implications for genital herpes caused by the same virus. The discovery from UVA’s Anna Cliffe, PhD, and colleagues seems to defy common… Continue reading New target identified for preventing cold sores and genital herpes

Published
Categorized as Immunology

Promising target in brain cancer

Scientists have discovered a previously unknown mechanism for how aggressive brain cancers reprogram immune system cells from fighting cancer to enabling further tumor growth.

Published
Categorized as Immunology

Atlantia Clinical Trials: Investigating the interrelation of microbiology and immunology

Thought LeadersLiam O’Mahony, Barry Skillington & John MacSharryProf. of Immunology, Cheif Commerical Officer & Research PartnerAtlantia and Clinical Trials Though most people know that their immune system is supported by microbes, the complexity and interrelation between the body’s microbial changes and wider health is something known only to those in the field. With over half the… Continue reading Atlantia Clinical Trials: Investigating the interrelation of microbiology and immunology

Published
Categorized as Immunology